The Alliance for Safe Biologic Medicines is an organization composed of diverse healthcare groups and individuals from patients to physicians, biotechnology companies that develop innovative and biosimilar medicines and others who are working together to ensure patient safety is at the forefront of the biosimilars policy discussion. The activities of the Alliance are funded by its member partners, who are all asked to contribute, with the primary funding provided by the Steering Committee. It is the mission of the Alliance to serve as an authoritative resource center of information for the public, medical community, the FDA and other government staff during the implementation of the biosimilars approval pathway and beyond.
Alliance for Patient Access
American Academy of Dermatology
American Autoimmune Related Diseases Association (AARDA)
Association of Clinical Research Organizations
Colon Cancer Alliance
Global Colon Cancer Association
Global Healthy Living Foundation
Hepatitis Foundation International
International Cancer Advocacy Network
Kidney Cancer Association
National Psoriasis Foundation
General Member Partners:
American Council on Science and Health
American Association of People with Disabilities
Association of Black Cardiologists
Association of Gastrointestinal Motility Disorders, Inc.
Biotechnology Industry Organization
Colorectal Cancer Coalition
Interamerican College of Physicians and Surgeons
Lupus and Allied Diseases Association, Inc.
National Alliance on Mental Illness